In conclusion, our study demonstrated that decreased expression of miR-24-3p and increased expression of miR-595 in patients with CAD may lead to progression of atherosclerosis plaque by regulating the expression of CCL3, CCL4, IL-1β, TNFαIP3, and NF-κBIα genes. This evidence concerns the gene TNFAIP3 and atherosclerosis.